Ken Griffin Aurinia Pharmaceuticals Inc. Transaction History
Citadel Advisors LLC
- $559 Billion
- Q4 2024
A detailed history of Ken Griffin (Citadel Advisors LLC) transactions in Aurinia Pharmaceuticals Inc. stock. As of the latest transaction made, Citadel Advisors LLC holds 138,000 shares of AUPH stock, worth $1.09 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
138,000
Previous 141,500
2.47%
Holding current value
$1.09 Million
Previous $1.04 Million
19.48%
% of portfolio
0.0%
Previous 0.0%
Shares
29 transactions
Others Institutions Holding AUPH
# of Institutions
227Shares Held
58.9MCall Options Held
949KPut Options Held
1.51M-
Black Rock Inc. New York, NY9.27MShares$73.5 Million0.0% of portfolio
-
Tang Capital Management LLC San Diego, CA8.43MShares$66.8 Million5.69% of portfolio
-
Armistice Capital, LLC New York, NY6.4MShares$50.8 Million0.81% of portfolio
-
Nea Management Company, LLC Timonium, MD3.97MShares$31.5 Million2.55% of portfolio
-
State Street Corp Boston, MA2.92MShares$23.1 Million0.0% of portfolio
About Aurinia Pharmaceuticals Inc.
- Ticker AUPH
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 141,892,000
- Market Cap $1.13B
- Description
- Aurinia Pharmaceuticals Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies to treat various diseases with unmet medical need in the United States and internationally. The company offers LUPKYNIS for the treatment of adult patients with active lupus nephritis. It has a collaboration and license...